Culina et al. (152) proposed that fetal introduction of preproinsulin (PPI), a common autoantigen in T1D, could result in the induction of tolerance to PPI and thereby reduce disease incidence in high risk neonates. This evidence concerns the gene INS and type 1 diabetes mellitus.